C. C. Under, J. By-nc-;-leon, C. Ruan, and H. Verdoux, No commercial re-use. See rights and permissions. Published by BMJ. to cite de

, General Psychiatry, vol.33, p.100183, 2020.

J. De and L. Http,

L. Bertilsson, J. A. Carrillo, and M. L. Dahl, Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test, Br J Clin Pharmacol, vol.38, pp.471-474, 1994.

C. Ruan, Y. Zang, and C. Wang, Clozapine metabolism in East Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review, J Clin Psychopharmacol, vol.39, pp.135-179, 2019.

C. Hiemke, N. Bergemann, and H. W. Clement, Consensus guidelines for therapeutic drug monitoring in Neuropsychopharmacology: update 2017, Pharmacopsychiatry, vol.51, pp.9-62, 2018.

W. H. Chang, S. K. Lin, and H. Y. Lane, Clozapine dosages and plasma drug concentrations, J Formos Med Assoc, vol.96, pp.599-605, 1997.

S. A. Chong, C. H. Tan, and Y. M. Khoo, Clinical evaluation and plasma clozapine concentrations in Chinese patients with schizophrenia, Ther Drug Monit, vol.19, pp.219-242, 1997.

J. De-leon, A. P. Rajkumar, and A. R. Kaithi, Do Asian patients require only half of the clozapine dose prescribed for Caucasians? A critical overview, Indian J Psychol Med, vol.42, pp.4-10, 2020.

C. Ruan, C. Wang, and Y. Tang, Exploring the prevalence of clozapine phenotypic poor metabolizers in 4 Asian samples: they ranged between 2% and 13, J Clin Psychopharmacol, vol.39, pp.644-652, 2019.

J. De-leon and F. J. Diaz, Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report, Prog Neuropsychopharmacol Biol Psychiatry, vol.27, pp.1059-63, 2003.

J. De-leon, Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature, J Clin Psychiatry, vol.65, pp.1144-1149, 2004.

S. R. Clark, N. S. Warren, and G. Kim, Elevated clozapine levels associated with infection: a systematic review, Schizophr Res, vol.192, pp.50-56, 2018.

C. Ruan, X. Zhang, and W. Guo, Two cases of high serum clozapine concentrations occurring during inflammation in Chinese patients, Int J Psychiatry Med, vol.53, pp.292-305, 2018.

C. Ruan, X. Zhen, and X. Ge, Pneumonia can cause clozapine intoxication: a case report, Psychosomatics, vol.58, pp.652-658, 2017.

C. Ruan, Y. Zang, and Y. Cheng, Around 3% of 1,300 levels were elevated during infections in a retrospective review of 131 beijing hospital in-patients with more than 24,000 days of clozapine treatment, Psychother Psychosom, vol.2020, p.3

C. Ruan and J. De-leon, Thirty years of both ignorance and clinical experience suggest that clozapine intoxication during co-occurring infections and inflammation may have higher morbidity and mortality than is currently believed, Psychosomatics, vol.60, pp.221-223, 2019.

H. Verdoux, C. Quiles, and J. De-leon, Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review, Schizophr Res, vol.211, pp.1-9, 2019.

J. De-leon, E. J. Sanz, D. Cuevas, and C. , Data from the world Health organization's pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions, Schizophr Bull, vol.46, pp.1-3, 2020.

K. J. Ronaldson, P. B. Fitzgerald, and J. J. Mcneil, Clozapine-Induced myocarditis, a widely overlooked adverse reaction, Acta Psychiatr Scand, vol.132, pp.231-271, 2015.

C. Rohde, C. Polcwiartek, and K. Kragholm, Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study, Acta Psychiatr Scand, vol.137, pp.47-53, 2018.

N. Chopra and J. De-leon, Clozapine-Induced myocarditis may be associated with rapid titration: a case report verified with autopsy, Int J Psychiatry Med, vol.51, pp.104-119, 2016.

J. De-leon, D. W. Rhee, and A. Kondracke, Rapid titration and decreased clozapine clearance may help explain five cases of clozapine-induced myocarditis in a new York Hospital, Psychosomatics, vol.61, pp.102-105, 2020.

N. Myles, H. Myles, and S. Xia, Meta-Analysis examining the epidemiology of clozapine-associated neutropenia, Acta Psychiatr Scand, vol.138, pp.101-110, 2018.

X. Li, X. Zhong, and L. Lu, The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies, Psychol Med, vol.50, pp.1-12, 2020.

P. Landry, F. Benaliouad, and S. Tessier, Increased use of antibiotics in clozapine-treated patients, Int Clin Psychopharmacol, vol.18, pp.297-305, 2003.

H. Liu, G. Hung, Y. , and S. , Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia, Psychiatry Clin Neurosci, vol.72, pp.789-800, 2018.

J. Nielsen, L. Foldager, and J. M. Meyer, Increased use of antibiotics in patients treated with clozapine, Eur Neuropsychopharmacol, vol.19, pp.483-489, 2009.

M. Ponsford, D. Castle, and T. Tahir, Clozapine is associated with secondary antibody deficiency, Br J Psychiatry, 2018.

G. Cicala, M. A. Barbieri, and E. Spina, A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults, Expert Rev Clin Pharmacol, vol.12, pp.219-253, 2019.

C. Kuo, Y. Liao, and Y. , Second-Generation antipsychotic medications and risk of pneumonia in schizophrenia, Schizophr Bull, vol.39, pp.648-57, 2013.

C. Rohde, D. Siskind, and J. De-leon, Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study, Acta Psychiatr Scand, 2019.

J. M. Vermeulen, G. Van-rooijen, and M. Van-de-kerkhof, Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years, Schizophr Bull, vol.45, pp.315-344, 2019.